Muñoz Raymundo A, Ramos Andrei A, Miranda Francisco J, De La Rosa José E, Muñoz Alfonzo E, Ramírez Aáron A, Chavez Eva P, Gallardo Guillermo, Pizarro Salvador
Department of Research and Medical Education, Hospital Angeles Chihuahua, Chihuahua, Mexico; Faculty of Medicine and Biomedical Sciences, Autonomous University of Chihuahua (UACH), Chihuahua, Mexico.
Department of General Surgery, Christus Muguerza Hospital del Parque, Chihuahua, Mexico.
J Surg Res. 2024 Dec;304:152-161. doi: 10.1016/j.jss.2024.10.018. Epub 2024 Nov 15.
There are studies with mixed conclusions about the role cholecystectomy plays as a risk factor for proximal colorectal cancer (CRC).
We performed a multicenter retrospective cohort study where the records of patients with CRC were reviewed. Data was collected regarding affected colon subsegment (cecum, ascending, transverse, descending, sigmoid, or rectum, which were also combined into proximal or distal colon), history and time since cholecystectomy, histopathology reports (TNM classification and clinical stage), and KRAS, NRAS, and BRAF mutation analysis. Univariate and multivariate analysis adjusting for age, smoking history, body mass index, sex, and family history of cancer were performed. Logistical regression for statistical analysis was used to estimate the odds ratio for the association between cholecystectomy and tumor location.
Four hundred four cases were obtained, of which 52 previously had cholecystectomy. The date of surgery was recorded in 43 patients, with a 5 y median and an interquartile range of 1.5-14 y prior to CRC diagnosis. Both crude and adjusted odds ratio (2.86 and 2.42, respectively) confirmed an associated risk for developing proximal CRC after cholecystectomy. When proximal CRC cases with previous cholecystectomy were directly compared against proximal CRC without cholecystectomy and distal CRC cases, the former had a higher distribution of prevalence for T3, T4b, N1b, M1a, and M1c. KRAS mutation also presented its highest prevalence in this group with 33%.
Cholecystectomy was related to the development of proximal CRC in all its subsegments, seemingly associated with higher stages at diagnosis. Close surveillance should be considered in patients who undergo cholecystectomy.
关于胆囊切除术作为近端结直肠癌(CRC)危险因素所起的作用,各项研究得出的结论不一。
我们开展了一项多中心回顾性队列研究,对CRC患者的记录进行了审查。收集了有关受累结肠亚段(盲肠、升结肠、横结肠、降结肠、乙状结肠或直肠,也合并为近端或远端结肠)、胆囊切除术后的病史和时间、组织病理学报告(TNM分类和临床分期)以及KRAS、NRAS和BRAF突变分析的数据。对年龄、吸烟史、体重指数、性别和癌症家族史进行了单因素和多因素分析。采用逻辑回归进行统计分析,以估计胆囊切除术与肿瘤位置之间关联的比值比。
共纳入404例病例,其中52例曾接受胆囊切除术。43例患者记录了手术日期,中位数为5年,在CRC诊断前的四分位间距为1.5 - 14年。粗比值比和调整后的比值比(分别为2.86和2.42)均证实胆囊切除术后发生近端CRC存在相关风险。将既往有胆囊切除术的近端CRC病例与无胆囊切除术的近端CRC病例及远端CRC病例直接比较时,前者在T3、T4b、N1b、M1a和M1c的患病率分布更高。KRAS突变在该组中的患病率也最高,为33%。
胆囊切除术与近端CRC各亚段的发生有关,似乎与诊断时的更高分期相关。对于接受胆囊切除术的患者,应考虑进行密切监测。